Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, digestive system neuroendocrine neoplasm, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor	Recruiting	Not stated	2026-03-20		NCT04090034

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Methodist Health System	34

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Clinical Research Institute at Methodist Health System	Dallas	United States	3
Methodist Dallas Medical Center	Dallas	United States	17

Clinical trials